Examining Genetic Variants Associated with FOXP1 Syndrome through Molecular Dynamics of Its DNA-Binding Domain and Self-Organizing Maps
Clinical Snapshot
PICO Framework
| P — Population | Six distinct missense variants in FOXP1 gene associated with FOXP1 syndrome |
| I — Intervention | Molecular dynamics simulations, molecular docking, and machine learning analysis via self-organizing maps |
| C — Comparator | Wild-type FOXP1 protein structure and DNA-binding interactions |
| O — Outcomes | Conformational changes, DNA-binding affinity alterations, and structural impact assessment of pathogenic variants |
Bottom Line
This computational study provides valuable structural insights into how missense variants in FOXP1 may cause neurodevelopmental dysfunction through altered DNA-binding capacity. The research establishes a framework combining molecular dynamics simulations with machine learning for variant interpretation, particularly highlighting the importance of helix H3 region mutations in disrupting protein-DNA interactions. While the computational approach is methodologically sound and the findings mechanistically plausible, the clinical utility remains limited without experimental validation. The work contributes to our understanding of FOXP1 syndrome pathogenesis and may inform future therapeutic strategies, but clinicians should await functional validation studies before incorporating these specific structural predictions into patient management decisions. The study represents an important step toward precision medicine approaches in neurodevelopmental disorders.
Key Findings
P Value: Not reported
Effect Size: Not quantitatively reported
Primary Outcome: Different conformational landscapes identified for FOXP1 variants with reduced DNA interactions for helix H3 mutations
Nnt Or Sensitivity: Structural framework for variant assessment established
Confidence Interval: Not provided
Clinical Application
Computational framework could be integrated into variant interpretation pipelines for clinical genetics services Relevant for Australian genetic pathology services and paediatric neurology practices; could inform TGA-approved genetic testing interpretation and support NHMRC-funded research initiatives Patients with FOXP1 syndrome and families undergoing genetic counselling for neurodevelopmental disorders
Abstract
Genetic mutations in the transcription factor FOXP1 (forkhead box protein P1) cause an autosomal dominant neurodevelopmental disorder called FOXP1 syndrome. To understand the structural impact of pathogenic variants associated with FOXP1 syndrome, we investigated the conformational changes resulting from six distinct missense variants in FOXP1 by combining molecular dynamics simulations, molecular docking, and machine learning via self-organizing maps. Our results reveal different conformational landscapes mapped by the FOXP1 variants and reduced interactions with the DNA for mutations residing in helix H3 of the DNA-binding domain. These analyses offer a framework for assessing the structural impact of missense variants implicated in the FOXP1 syndrome, highlighting the importance of structural inferences in interpreting genetic variants.
References
- 1.Motta, S., Perta, N., Romagnoli, A., Rexha, J., Buxbaum, J. D., De Rubeis, S., & Di Marino, D. (2026). Examining genetic variants associated with FOXP1 syndrome through molecular dynamics of its DNA-binding domain and self-organizing maps. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c00080
Related Research
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Genetics versus environment in the pathophysiology of sagittal synostosis
19 July 2026
Nucleic acids research
FABIAN-variant 2026: improved prediction of the effects of DNA variants on transcription factor binding
13 July 2026
BioEssays : news and reviews in molecular, cellular and developmental biology
AI in Genomics: From Variant Calling to Multi-Omics Integration
3 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service